Related Experiment Video
Updated: Aug 19, 2026
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
Microarray-based prediction of cytotoxicity of tumor cells to cantharidin
1German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. thomas.efferth@web.de
Abstract:
Cantharidin (CAN) is the active principle of the Chinese blister beetle (Mylabris phalerata) which exerts profound cytotoxicity towards tumor cells. The aim of this study was to identify the molecular determinants of sensitivity and resistance of tumor cells to CAN. We mined the microarray database of the National Cancer Institute (NCI), for genes whose expression correlated with the IC(50) values for CAN of 60 cell lines of different tumor types. By COMPARE analysis Kendall's tau test, and false discovery rate (FDR) analysis, 21 out of 9706 genes or expressed sequence tags (ESTs) were identified. If the mRNA expression of the 21 genes or ESTs was subjected to hierarchical cluster analysis and cluster image mapping, sensitivity or resistance of the 60 cell lines to CAN was predictable with statistical significance. The majority of these genes are involved in DNA damage response, DNA repair, and/or apoptosis. In conclusion, sensitivity or resistance of tumor cells to CAN is multi-factorial in nature. DNA repair and apoptosis play a major role as determinants of cellular response to CAN. The present investigation represents a starting point to dissect the genes and molecular pathways responsible for cellular response to cantharidin in more detail.
Insights
Cantharidin (CAN) shows anti-cancer properties. Researchers identified 21 genes linked to tumor cell sensitivity or resistance to CAN, primarily involved in DNA repair and apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacogenomics
Background:
- Cantharidin (CAN), derived from the Chinese blister beetle, exhibits significant cytotoxicity against tumor cells.
- Understanding the molecular basis of tumor cell sensitivity and resistance to CAN is crucial for its therapeutic application.
Purpose of the Study:
- To identify molecular determinants governing tumor cell sensitivity and resistance to Cantharidin (CAN).
- To correlate gene expression profiles with Cantharidin IC(50) values across diverse tumor cell lines.
Main Methods:
- Utilized the National Cancer Institute's (NCI) microarray database containing 60 tumor cell lines.
- Employed COMPARE analysis, Kendall's tau test, and false discovery rate (FDR) analysis to identify significant gene correlations.
- Applied hierarchical cluster analysis and cluster image mapping to assess predictability of CAN sensitivity/resistance based on gene expression.
Main Results:
- Identified 21 out of 9706 genes/ESTs whose mRNA expression correlated with CAN IC(50) values.
- Demonstrated that mRNA expression of these 21 genes could significantly predict sensitivity or resistance of tumor cells to CAN.
- Found that the majority of identified genes are involved in DNA damage response, DNA repair, and apoptosis pathways.
Conclusions:
- Tumor cell sensitivity and resistance to Cantharidin are multifactorial.
- DNA repair and apoptosis are key determinants of cellular response to Cantharidin.
- This study provides a foundation for further detailed investigation into genes and molecular pathways governing cellular response to CAN.
